-+ 0.00%
-+ 0.00%
-+ 0.00%
Novavax to Participate in Jefferies London Healthcare Conference
Share
Listen to the news

GAITHERSBURG, Md., Nov. 11, 2026 /PRNewswire/ -- Novavax, Inc. (Nasdaq: NVAX) today announced that company management will participate in the following upcoming investor conference:

  • Jefferies London Healthcare Conference, London, United Kingdom

    Fireside chat on Tuesday, November 17, 2026, at 5:00 p.m. GMT

A live webcast of the fireside chat will be available on the "Events & Presentations" page of the Company's website at ir.novavax.com. A replay of each webcast will be available for 30 days following the presentation.

About Novavax

Novavax, Inc. (Nasdaq: NVAX) tackles some of the world's most pressing health challenges with its scientific expertise in vaccines and its proven technology platform, including its Matrix-M® adjuvant and protein-based nanoparticles. The Company's corporate growth strategy is designed to deliver value via three key strategic pillars: partnering its technology, capital-efficient research and development (R&D) innovation and a lean and efficient operating model. This includes maximizing impact through partnerships for its marketed products (Nuvaxovid™, R21/Matrix-M™), Matrix technology and research and development assets. Please visit novavax.com and LinkedIn for more information. 

Contacts:

Investors

Naina Zaman 

240-410-5353  

ir@novavax.com 

Media 

Yvonne Sprow 

240-720-7804  

media@novavax.com 

Novavax Logo

 

Cision View original content to download multimedia:https://www.prnewswire.com/news-releases/novavax-to-participate-in-jefferies-london-healthcare-conference-302936885.html

SOURCE Novavax, Inc.

Disclaimer:This article represents the opinion of the author only. It does not represent the opinion of Webull, nor should it be viewed as an indication that Webull either agrees with or confirms the truthfulness or accuracy of the information. It should not be considered as investment advice from Webull or anyone else, nor should it be used as the basis of any investment decision.
What's Trending